NEXTCURE, INC Shares Issued
NEXTCURE, INC (NXTC) had Shares Issued of 4.07 million shares as of 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-18
- 2026-06-30: Common Stock, Shares, Issued 4.07M shares.
- 2026-03-31: Common Stock, Shares, Issued 3.61M shares.
- 2025-12-31: Common Stock, Shares, Issued 3.51M shares.
- 2025-09-30: Common Stock, Shares, Issued 2.68M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 4.07M shares S-4 · filed 2026-08-18 | |
| 2026-03-31 | 3.61M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 3.51M shares S-4 · filed 2026-08-18 | |
| 2025-09-30 | 2.68M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 2.34M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 28.01M shares 10-Q · filed 2025-05-01 | |
| 2024-12-31 | 2.33M shares S-4 · filed 2026-08-18 | 28.01M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 27.98M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 27.98M shares 10-Q · filed 2024-08-01 | |
| 2024-03-31 | 27.90M shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 27.90M shares 10-K · filed 2025-03-06 | |
| 2023-09-30 | 27.84M shares 10-Q · filed 2023-11-02 | |
| 2023-06-30 | 27.84M shares 10-Q · filed 2023-08-03 | |
| 2023-03-31 | 27.77M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 27.77M shares 10-K · filed 2024-03-21 | |
| 2022-09-30 | 27.75M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 27.75M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 27.73M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 27.68M shares 10-K · filed 2023-03-02 | |
| 2021-09-30 | 27.62M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 27.61M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 27.60M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 27.57M shares 10-K · filed 2022-03-03 | |
| 2020-09-30 | 27.55M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 27.52M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 27.52M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 27.50M shares 10-K · filed 2021-03-04 | |
| 2019-09-30 | 22.74M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 22.71M shares 10-Q · filed 2019-08-12 | |
| 2019-03-31 | 1.38M shares 10-Q · filed 2019-06-10 | |
| 2018-12-31 | 1.37M shares 10-K · filed 2020-03-12 | 1.38M shares 10-Q · filed 2019-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |